DSM Biologics and Crucell Announce Licensing Agreement With Medarex

DSM Biologics, a business unit of DSM Pharmaceutical Products, and Dutch biotechnology company Crucell N.V. announced a PER.C6 license agreement with biopharmaceutical company Medarex, Inc.
CNN Money